1K

Shares

News site default image

CRISPR used for first time to correct clotting in newborn and adult mice

Shared by Radhika Narayanan | 757 294 9 | about 2 years ago

CRISPR/Cas9, a powerful genome editing tool, is showing promise for efficient correction of disease-causing mutations. For the first time, researchers have developed a dual gene therapy approach to deliver key components of a CRISPR/Cas9-mediated gene targeting system to mice to treat hemophilia B. This disorder is also called factor IX deficiency and is caused by a missing or defective clotting protein.

Read More On www.sciencedaily.com

Categories Digital Biology & Genetics Integrated Omics

Related Post

Links

https://www.sciencedaily.com/releases/2016/11/161130125611.htm
http://www.sciencedaily.stfi.re/releases/2016/11/161130125611.htm?sf=rgzxbgv
http://stfi.re/rgzxbgv
http://bit.ly/2gXYX4v

1 Votes

You must log in to post a comment

0 Comments